Weekly signal · HUM · Healthcare

Humana Inc (HUM) rebounds as weekly participation lags

The healthcare-plan stock is recovering strongly, but volume remains below its recent weekly norm.

Humana Inc
Latest379.22 USD
1W move8.3%
Volume0.7x
TrendActive
Finance desk with a weekly stock chart and healthcare insurance plan documents representing Humana market coverage.

Market update

What happened

Humana Inc (HUM) closed at 379.22 USD in the latest weekly market data, gaining 8.3% for the week as the managed-care stock continued its rebound.

The setup is constructive but not one-sided. The trend state is active and Market Dynamics shows confirmation at 0.97, while Relative Strength remains modest at 38.5.

The weekly price path over 52 weeks shows a broader recovery, with HUM up 24.3% over four weeks and 124.4% over twelve weeks.

Continue your research

Explore HUM across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

HUM coverage

Evidence context